Alnylam Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02043Q1076
  • NASDAQ: ALNY
USD
251.65
7.33 (3.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlnylam Pharmaceuticals, Inc. VS Pharmaceuticals & Biotechnology
 
1D
3%
0%
1W
5.62%
2.36%
1M
6.53%
1.18%
YTD
-36.72%
13.43%
1Y
-45.16%
16%
3Y
46.69%
79.73%
5Y
38.11%
76.64%
10Y
226.44%
256.64%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.14%
0%
-12.14%
6 Months
-19.39%
0%
-19.39%
1 Year
-45.16%
0%
-45.16%
2 Years
-8.12%
0%
-8.12%
3 Years
46.69%
0%
46.69%
4 Years
24.14%
0%
24.14%
5 Years
38.11%
0%
38.11%

Alnylam Pharmaceuticals, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading